Together, resveratrol can act as NFκB inhibitor in adipocytes and thus the subsequently reduced PAI-1 expression in inflamed adipose tissue might provide a new insight towards novel treatment options of obesity. This evidence concerns the gene NFKB1 and obesity due to melanocortin 4 receptor deficiency.